Michael E Bozik Selected Research

Biomarkers (Surrogate Marker)

9/2014

A post hoc analysis of subgroup outcomes and creatinine in the phase III clinical trial (EMPOWER) of dexpramipexole in ALS.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael E Bozik Research Topics

Disease

8	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2019 - 01/2008
2	Eosinophilia 11/2023 - 01/2019
2	Hypereosinophilic Syndrome (Loeffler Endocarditis) 01/2018 - 01/2017
2	Disease Progression 01/2018 - 09/2014
1	Asthma (Bronchial Asthma) 11/2023
1	Rhinosinusitis 01/2019
1	Nasal Polyps (Nasal Polyp) 01/2019
1	Polyps 01/2019
1	Respiratory Insufficiency (Respiratory Failure) 01/2018
1	Infections 01/2017
1	Neutropenia 11/2013
1	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2011

Drug/Important Bio-Agent (IBA)

9	DexpramipexoleIBA 11/2023 - 01/2008
1	Investigational DrugsIBA 01/2019
1	SteroidsIBA 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2017
1	CreatinineIBA 09/2014
1	Biomarkers (Surrogate Marker)IBA 09/2014
1	DiaminesIBA 08/2011
1	benzothiazoleIBA 08/2011

Therapy/Procedure

3	Therapeutics 11/2023 - 01/2017
1	Tracheostomy 01/2018